" class="no-js "lang="en-US"> Intravacc - Medtech Alert
Tuesday, September 23, 2025
Intravacc | Pharmtech Focus

Intravacc

About Intravacc

Intravacc

Even the most promising vaccines don’t always make it out of the laboratory into large-scale production. We at Intravacc are fully aware of the challenges on the long road of vaccine development.
We substantially reduce the risks and costs involved with developing vaccines. How? By bridging the gap between your concept and late stage clinical studies.
As an established independent CDMO in the vaccine industry, Intravacc offers a wide range of expertise and is the bridge between your discovery and the start of your phase I/II clinical trials in humans.
Part of Utrecht Science Park Bilthoven

Related Story

Leiden Medical Center and Intravacc to Start Clinical Trial with New Intranasal Corona Vaccine

January 5 2022

Intravacc, a global leader in translational research and development of therapeutic vaccines and vaccines against […]